Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.

Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays Revision: v3.6.5 in place of the previous v3.6.4, indicating a minor update to the study record metadata. This change does not modify the study details or user-facing content.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a backend update. No study information or layout changes are introduced.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page's revision label changed from v3.6.2 to v3.6.3, indicating a newer revision of the page. This is a minor update applied to the page's underlying revision tag.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 to indicate a newer page revision. This change is metadata and does not modify the study content or its presentation.SummaryDifference0.1%

- Check66 days agoChange DetectedThe study page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and displays recruitment status as 'No longer looking for participants'. The Intervention/Treatment heading is updated and the revision footer shows Revision: v3.6.0.SummaryDifference0.4%

- Check74 days agoChange DetectedThe page displays an updated revision label: Revision: v3.5.5, replacing the previous Revision: v3.5.4.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.